Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-06

Clinical Trial Update: AZMATICS: AZithroMycin/Asthma Trial In Community Settings [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for AZMATICS (AZithroMycin) in asthma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZMATICS (AZithroMycin)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2019-09-06